BioPorto Statistics
Total Valuation
BioPorto has a market cap or net worth of 78.47 million. The enterprise value is 75.41 million.
| Market Cap | 78.47M |
| Enterprise Value | 75.41M |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 495.10M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +12.04% |
| Shares Change (QoQ) | +1.47% |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 0.16% |
| Float | 492.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.66 |
| PB Ratio | 14.20 |
| P/TBV Ratio | 14.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.53 |
| EV / Sales | 12.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.90 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.91 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -57.52 |
Financial Efficiency
Return on equity (ROE) is -142.61% and return on invested capital (ROIC) is -81.09%.
| Return on Equity (ROE) | -142.61% |
| Return on Assets (ROA) | -61.71% |
| Return on Invested Capital (ROIC) | -81.09% |
| Return on Capital Employed (ROCE) | -217.77% |
| Weighted Average Cost of Capital (WACC) | 11.18% |
| Revenue Per Employee | 119,659 |
| Profits Per Employee | -284,071 |
| Employee Count | 48 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 2.55 |
Taxes
| Income Tax | -1.03M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.91% in the last 52 weeks. The beta is 1.25, so BioPorto's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +30.91% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.74 |
| Average Volume (20 Days) | 46,655 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioPorto had revenue of 5.74 million and -13.64 million in losses. Loss per share was -0.03.
| Revenue | 5.74M |
| Gross Profit | 3.67M |
| Operating Income | -13.73M |
| Pretax Income | -14.66M |
| Net Income | -13.64M |
| EBITDA | -13.60M |
| EBIT | -13.73M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 4.33 million in cash and 1.31 million in debt, with a net cash position of 3.03 million.
| Cash & Cash Equivalents | 4.33M |
| Total Debt | 1.31M |
| Net Cash | 3.03M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.53M |
| Book Value Per Share | 0.01 |
| Working Capital | 4.01M |
Cash Flow
In the last 12 months, operating cash flow was -12.51 million and capital expenditures -269,893, giving a free cash flow of -12.78 million.
| Operating Cash Flow | -12.51M |
| Capital Expenditures | -269,893 |
| Free Cash Flow | -12.78M |
| FCF Per Share | n/a |
Margins
Gross margin is 63.90%, with operating and profit margins of -238.98% and -237.40%.
| Gross Margin | 63.90% |
| Operating Margin | -238.98% |
| Pretax Margin | -255.29% |
| Profit Margin | -237.40% |
| EBITDA Margin | -236.70% |
| EBIT Margin | -238.98% |
| FCF Margin | n/a |
Dividends & Yields
BioPorto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.04% |
| Shareholder Yield | -12.04% |
| Earnings Yield | -17.38% |
| FCF Yield | -16.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioPorto has an Altman Z-Score of 0.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.16 |
| Piotroski F-Score | 2 |